학술논문
Retrospective, real-life study of venetoclax plus azacitidine or low-dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy
Document Type
Article
Author
Laloi, L.; Billotey, N.C.; Dumas, P.-Y.; Pigneux, A.; Paul, F.; Villate, A.; Simand, C.; Fornecker, L.; Puisset, F.; Bertoli, S.; Récher, C.; Simonet, M.B.; Laribi, K.; Houyou, D.; Santagostino, A.; Michel, C.; Guepin, G.R.; Guerineau, E.; Tabrizi, R.; Hunault, M.; Giltat, A.; Kaphan, E.; Bulabois, C.; Cartet, E.; Rocher, C.; Lachenal, F.; Morisset, S.; Belhabri, A.; Michallet, M.; Michallet, A.-S.
Source
In: Cancer Medicine . (Cancer Medicine, March 2023, 12(6):7175-7181)
Subject
Language
English
ISSN
20457634